Evidence map›Paper›PMID 42181656›Full record

ReviewClinical, cosmetic and investigational dermatology2026

Corticosteroid Phobia in Patients with Atopic Dermatitis: A Narrative Review.

Xue Chen, Zhirun Wang

Abstract readReview
In one paragraph

Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xue ChenMedicine School of Lishui University, Lishui University, Lishui, Zhejiang Province, People's Republic of China.ORCID 0009-0000-8642-256X
Zhirun WangMedicine School of Lishui University, Lishui University, Lishui, Zhejiang Province, People's Republic of China.ORCID 0009-0004-1035-7473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease worldwide, often accompanied by the complex progression of atopic conditions. This article reviews the current state of fear regarding corticosteroid treatment among patients with AD, analyzes the influencing factors and its impact on treatment adherence, integrates epidemiological data and pathogenesis, and examines the clinical advantages and limitations of corticosteroids in AD management. By critically evaluating the effectiveness of existing health education, psychological interventions, and personalized care strategies, this article aims to identify current research gaps and provide evidence-based guidance for optimizing standardized care pathways and improving patient outcomes.

Indexed as

atopic dermatitiscorticosteroid phobiaglucocorticoidsnursing strategiesreview

Identifiers

PMID42181656
PMCPMC13196724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.